| Authors: |
Banerjee S; Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK., Oza AM; Princess Margaret Hospital, Toronto, Canada., Birrer MJ; Massachusetts General Hospital, Boston, USA; Harvard Medical School, Boston, USA., Hamilton EP; Sarah Cannon Research Institute, Nashville, USA; Tennessee Oncology, Nashville, USA., Hasan J; The Christie Hospital, Manchester, UK., Leary A; Gustave Roussy Cancer Centre, Paris, France., Moore KN; University of Oklahoma Health Sciences Center, Oklahoma City, USA., Mackowiak-Matejczyk B; Bialystok Oncology Center, Bialystok, Poland., Pikiel J; Regional Center of Oncology, Gdańsk, Poland., Ray-Coquard I; Centre Léon Bérard Centre Régional de Lutte Contre Le Cancer Rhône Alpes, Lyon, France., Trask P; Genentech, Inc., South San Francisco, USA., Lin K; Genentech, Inc., South San Francisco, USA., Schuth E; Genentech, Inc., South San Francisco, USA., Vaze A; Genentech, Inc., South San Francisco, USA., Choi Y; Genentech, Inc., South San Francisco, USA., Marsters JC; Genentech, Inc., South San Francisco, USA., Maslyar DJ; Genentech, Inc., South San Francisco, USA., Lemahieu V; Genentech, Inc., South San Francisco, USA., Wang Y; Genentech, Inc., South San Francisco, USA., Humke EW; Genentech, Inc., South San Francisco, USA., Liu JF; Harvard Medical School, Boston, USA; Gynecologic Oncology Program, Dana-Farber Cancer Institute, Boston, USA. Electronic address: joyce_liu@dfci.harvard.edu. |
